3-Arylcoumarin inhibits vascular calcification by inhibiting the generation of AGEs and anti-oxidative stress
Objective This work aims to screen drugs for preventing and treating vascular calcification. Method: We screened a series of 3-arylcoumarins for the detection of vascular calcification-associated factors using human aortic vascular smooth muscle cells.Results We found that compounds 14 and 32 signif...
Main Authors: | YuFei Li, Yinbo Pan, Liying Wang, Xiaojing Wang, Haiping Chu, Yan Li, Jie Sun, Yanling Mu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | Journal of Enzyme Inhibition and Medicinal Chemistry |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/14756366.2022.2109024 |
Similar Items
-
Natural source, bioactivity and synthesis of 3-Arylcoumarin derivatives
by: Qiang Zhang, et al.
Published: (2022-12-01) -
Recent Advances in Synthesis of 4-Arylcoumarins
by: Jong-Wha Jung, et al.
Published: (2018-09-01) -
Molecular Mechanism of Calycosin Inhibited Vascular Calcification
by: Zekun Zhou, et al.
Published: (2023-12-01) -
Synthesis and Structure-Activity Relationships of Novel Amino/Nitro Substituted 3-Arylcoumarins as Antibacterial Agents
by: Ysabel Santos, et al.
Published: (2013-01-01) -
Synthesis of New 3-Arylcoumarins Bearing N-Benzyl Triazole Moiety: Dual Lipoxygenase and Butyrylcholinesterase Inhibitors With Anti-Amyloid Aggregation and Neuroprotective Properties Against Alzheimer’s Disease
by: Ladan Pourabdi, et al.
Published: (2022-01-01)